12:00 AM
 | 
Apr 22, 2013
 |  BC Week In Review  |  Company News  |  Deals

ANI Pharmaceuticals, BioSante deal

ANI and BioSante entered into a new stock deal under which the companies will merge, with former ANI shareholders owning a 57% stake of the combined company and former BioSante shareholders owning the remaining stake. Under the deal proposed last October, former...

Read the full 190 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >